AVXLNasdaq

ANAVEX LIFE SCIENCES CORP.

Biological Products, (No Diagnostic Substances) · CIK 1314052

Develops precision medicine therapeutics for CNS diseases by targeting sigma-1 receptors to restore cellular homeostasis

red 8-K · 90d

$232M

Market cap

$2.59

Last close

-0.4%

+0.4%

893K

Volume

Price · last 40 sessions-24.0%

May 4L $2.46 · H $3.41Jun 30

252

Total filings

Jun 26, 2026

Last filing

09/30

Fiscal year end

Similar companies

Comparable business profile · signals at a glance